Hot Topics in Thyroid Cancer

In this video interview, Alan L. Ho, MD, PhD, Geoffrey Beene Junior Faculty Chair at Memorial Sloan Kettering Cancer Center, discussed the latest developments in targeted therapies for thyroid cancer, the most important factors that inform treatment options, the challenges involved in the timing of treatment initiation and how management of adverse events can secure patient compliance and treatment outcomes.

In this video, Ho discusses:

• Latest developments in targeted therapies for thyroid cancer;
• Factors that inform treatment options;
• Challenges involved in timing of treatment; and
• Unmet needs of patients with thyroid cancer.